http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5424428-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af737d167c026fd865fb68df681ea49a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B57-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-14
filingDate 1992-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1995-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e96da627c54c453b26079735820f0a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_540bb1686d694eadf3ec3a6abdc2f91b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a23d652250301270d79206fe1e3b3f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22a413175d3753104d4b8d251bb2fec8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_416d8d5d58ff788db053fcfbda93f7b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb462d4922b0a91af9aafca14b4eae6c
publicationDate 1995-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5424428-A
titleOfInvention (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]pr
abstract PCT No. PCT/FI92/00003 Sec. 371 Date Jun. 30, 1993 Sec. 102(e) Date Jun. 30, 1993 PCT Filed Jan. 3, 1992 PCT Pub. No. WO92/12135 PCT Pub. Date Jul. 23, 1992.Optically substantially pure (-) enantiomer of [[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono)propanedinitrile or pharmaceutically acceptable salt thereof, intermediates and a process for the preparation are described. The product is useful as a cardiotonic agent, antihypertensive and vasodilator for the treatment of congestive heart failure.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006293395-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004092523-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008153827-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6911209-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6943164-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004106617-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103554032-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111548310-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7279479-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005107756-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6730673-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111548310-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111718299-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111718299-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0128560-A1
priorityDate 1991-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4843072-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0208518-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5151420-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4946842-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9212135-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5019575-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4521415-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4914093-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2251615-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135960051
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234401267
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127680204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226459474
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88389661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88389662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234401050
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128766002
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60867
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411262
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11073729
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10989605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127836869
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127927562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8010
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129232388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57111887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22853916
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148570
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11734
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227196635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412622
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234401051

Total number of triples: 80.